795 related articles for article (PubMed ID: 30701936)
1. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
Yurenev GL; Partzvania-Vinogradova EV; Andreev DN; Dicheva DT; Maiev IV
Ter Arkh; 2018 Aug; 90(8):33-39. PubMed ID: 30701937
[TBL] [Abstract][Full Text] [Related]
3. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Song KH; Lee YC; Fan DM; Ge ZZ; Ji F; Chen MH; Jung HC; Bo J; Lee SW; Kim JH
Digestion; 2011; 84(3):221-9. PubMed ID: 21757914
[TBL] [Abstract][Full Text] [Related]
4. Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
Nebiki H; Higuchi K; Arakawa T; Ando K; Uchida T; Ito H; Harihara S; Kuroki T; Kobayashi K
Dig Dis Sci; 1998 Sep; 43(9 Suppl):203S-206S. PubMed ID: 9753251
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of Helicobacter pylori in Chinese peptic ulcer patients.
Sun WH; Ou XL; Cao DZ; Yu Q; Yu T; Hu JM; Zhu F; Sun YL; Fu XL; Su H
World J Gastroenterol; 2005 Apr; 11(16):2477-81. PubMed ID: 15832421
[TBL] [Abstract][Full Text] [Related]
6. Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.
Felga G; Silva FM; Barbuti RC; Navarro-Rodriguez T; Zaterka S; Eisig JN
J Infect Dev Ctries; 2010 Nov; 4(11):712-6. PubMed ID: 21252448
[TBL] [Abstract][Full Text] [Related]
7. Comparison of rabeprazole-based four- and seven-day triple therapy and omeprazole-based seven-day triple therapy for Helicobacter pylori infection in patients with peptic ulcer.
Yang KC; Wang GM; Chen JH; Chen TJ; Lee SC
J Formos Med Assoc; 2003 Dec; 102(12):857-62. PubMed ID: 14976565
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Sugiyama T; Kato M; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S
Helicobacter; 2001 Sep; 6(3):254-61. PubMed ID: 11683930
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
Kato S; Takeyama J; Ebina K; Naganuma H
Pediatrics; 1997 Jul; 100(1):E3. PubMed ID: 9200377
[TBL] [Abstract][Full Text] [Related]
10. Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide.
Hahm KB; Lee KJ; Kim YS; Kim JH; Cho SW; Yim H; Joo HJ
Dig Dis Sci; 1998 Feb; 43(2):235-40. PubMed ID: 9512112
[TBL] [Abstract][Full Text] [Related]
11. [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].
Isakov VA; Maev IV; Simanenkov VI; Kononov AV; Abdulkhakov RA; Zakharova NV; Livzan MA; Predvechnaia IK
Ter Arkh; 2003; 75(11):71-3. PubMed ID: 14708448
[TBL] [Abstract][Full Text] [Related]
12. [The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease].
Veliev AM; Maev IV; Andreev DN; Dicheva DT; Zaborovskii AV; Lobanova EG; Bektemirova LG
Ter Arkh; 2019 Aug; 91(8):28-33. PubMed ID: 32598751
[TBL] [Abstract][Full Text] [Related]
13. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study.
Assem M; El Azab G; Rasheed MA; Abdelfatah M; Shastery M
Eur J Intern Med; 2010 Aug; 21(4):310-4. PubMed ID: 20603042
[TBL] [Abstract][Full Text] [Related]
15. [The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen].
Kim J; Kim K; Lee JS; Kim SY; Kim KO; Kim YJ; Kwon KA; Park DK; Chung JW
Korean J Gastroenterol; 2018 Apr; 71(4):204-212. PubMed ID: 29684969
[TBL] [Abstract][Full Text] [Related]
16. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
[TBL] [Abstract][Full Text] [Related]
17. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
Lüth S; Teyssen S; Kölbel CB; Singer MV
Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
[TBL] [Abstract][Full Text] [Related]
18. A short-term eradication therapy for Helicobacter pylori acute gastritis.
Nomura H; Miyake K; Kashiwagi S; Sugiyama T; Asaka M
J Gastroenterol Hepatol; 2000 Dec; 15(12):1377-81. PubMed ID: 11197046
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori eradication in inactive peptic ulcer disease and the efficiency of sequential therapy in inactive peptic ulcer disease and non-ulcer dyspepsia.
Chan CC; Chien NH; Lee CL; Yang YC; Hung CS; Tu TC; Wu CH
BMC Gastroenterol; 2015 Dec; 15():170. PubMed ID: 26635102
[TBL] [Abstract][Full Text] [Related]
20. A pilot study to evaluate a new combination therapy for gastric ulcer: Helicobacter pylori eradication therapy followed by gastroprotective treatment with rebamipide.
Terano A; Arakawa T; Sugiyama T; Yoshikawa T; Haruma K; Asaka M; Shimosegawa T; Sakaki N; Ishii H; Sakamoto C; Takahashi S; Kinoshita Y; Fujioka T; Kobayashi K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):103-9. PubMed ID: 16706820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
